Who
Peter Anastasiou
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Harmony Biosciences Holdings.
In numbers
- Trades disclosed
- 5
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Nov 2023
- Last trade
- 2 Apr 2026
- Last filed
- 6 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 6 Apr 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —212,241 at $0.00 | filing |
| 2 Apr 2026filed 6 Apr 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —212,241 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,522 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,336 at $0.00 | filing |
| 5 Nov 2023filed 8 Nov 2023 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,771 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.